Clinical Trial Results TV
March 9, 2013: Dr. Jane Margaret Armitage and Dr. C. Michael Gibson discuss: HPS2-THRIVE: Randomized Comparison Of Extended-Release (ER
Dr. Jane Margaret Armitage and Dr. C. Michael Gibson discuss: HPS2-THRIVE: Randomized
Comparison Of Extended-Release (ER) niacin/laropiprant 2g Daily Versus Placebo in 25,673
Patients At High Risk Of Occlusive Vascular Events

Grant to Oxford University. Designed, conducted and analysed independently of the grant
source (Merck & Co). No honoraria or consultancy fees accepted.


[ Download video ]


Video Statistics
4 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 6 total votes.

These statistics are updated nightly. The last update ran on
06-26-2017 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted